This study sought to determine whether the presence of a coronary stent affected the timing of colorectal cancer resection and the postoperative outcomes.
This is an Invited Commentary on a retrospective review on the effect of margin positivity on survival among patients with colon cancer.
This cohort study explores the effect of radial margin positivity on perioperative outcomes as well as survival and disease-free survival in colon cancer.
This study of patients with colon cancer from the SEER database evaluated the effect of inclusion of C stage into standard cancer staging and the implications on survival estimates.
This nationwide cohort study defines stage-specific treatments and prognosis of colon cancer diagnosed in young adults (ages 18-49 years) vs older adults (ages 65-75 years).
This retrospective cohort study using the Surveillance, Epidemiology, and End Results registry reports that there has been a significant increase in the incidence of colorectal cancer diagnosed in young adults, with a decline in older patients. Turaga provides a related editorial.
This hierarchical multivariable logistic regression analysis of observational data found little risk-adjusted variation in hospital readmission rates after colorectal surgery. See also the Invited Commentary by Opelka.
Jafari et al examine the surgical trends and outcomes of colorectal cancer treatment in the elderly.
Aboagye et al examine the disparities that may exist in colorectal cancer screening and treatment by comparing the distribution of providers of these services in rural and urban counties in the United States.
Amri et al assess the effect of screening colonoscopy on outcomes of colon cancer surgery by reviewing differences in staging, disease-free interval, risk of recurrence, and survival and identify whether diagnosis through screening improves long-term outcomes independent of staging.
Winner et al conducted a large population-based study to investigate the incidence and risk factors associated with bowel obstruction in elderly patients with stage IV colon cancer. An invited critique by Krouse follows.